115 related articles for article (PubMed ID: 20072157)
21. Combined effects of the two reciprocal t(4;11) fusion proteins MLL.AF4 and AF4.MLL confer resistance to apoptosis, cell cycling capacity and growth transformation.
Gaussmann A; Wenger T; Eberle I; Bursen A; Bracharz S; Herr I; Dingermann T; Marschalek R
Oncogene; 2007 May; 26(23):3352-63. PubMed ID: 17130830
[TBL] [Abstract][Full Text] [Related]
22. Modeling the initiation and progression of human acute leukemia in mice.
Barabé F; Kennedy JA; Hope KJ; Dick JE
Science; 2007 Apr; 316(5824):600-4. PubMed ID: 17463288
[TBL] [Abstract][Full Text] [Related]
23. Genetic stability of human embryonic stem cells: A first-step toward the development of potential hESC-based systems for modeling childhood leukemia.
Catalina P; Bueno C; Montes R; Nieto A; Ligero G; Sanchez L; Jara M; Rasillo A; Orfao A; Cigudosa J; Hovatta O; Greaves M; Menendez P
Leuk Res; 2009 Jul; 33(7):980-90. PubMed ID: 18930318
[TBL] [Abstract][Full Text] [Related]
24. Establishment of a myeloid leukemia cell line, TRL-01, with MLL-ENL fusion gene.
Ninomiya M; Abe A; Yokozawa T; Ozeki K; Yamamoto K; Ito M; Ito M; Kiyoi H; Emi N; Naoe T
Cancer Genet Cytogenet; 2006 Aug; 169(1):1-11. PubMed ID: 16875930
[TBL] [Abstract][Full Text] [Related]
25. Acute myeloid leukemia induced by MLL-ENL is cured by oncogene ablation despite acquisition of complex genetic abnormalities.
Horton SJ; Walf-Vorderwülbecke V; Chatters SJ; Sebire NJ; de Boer J; Williams O
Blood; 2009 May; 113(20):4922-9. PubMed ID: 19029444
[TBL] [Abstract][Full Text] [Related]
26. Meis2 as a critical player in MN1-induced leukemia.
Lai CK; Norddahl GL; Maetzig T; Rosten P; Lohr T; Sanchez Milde L; von Krosigk N; Docking TR; Heuser M; Karsan A; Humphries RK
Blood Cancer J; 2017 Sep; 7(9):e613. PubMed ID: 28960191
[TBL] [Abstract][Full Text] [Related]
27. MLL1 and DOT1L cooperate with meningioma-1 to induce acute myeloid leukemia.
Riedel SS; Haladyna JN; Bezzant M; Stevens B; Pollyea DA; Sinha AU; Armstrong SA; Wei Q; Pollock RM; Daigle SR; Jordan CT; Ernst P; Neff T; Bernt KM
J Clin Invest; 2016 Apr; 126(4):1438-50. PubMed ID: 26927674
[TBL] [Abstract][Full Text] [Related]
28. The mechanism of hematopoietic progenitor cell immortalization by MLL-ENL.
Horton SJ; Williams O
Cell Cycle; 2006 Feb; 5(4):360-2. PubMed ID: 16479159
[TBL] [Abstract][Full Text] [Related]
29. High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogenetics.
Heuser M; Beutel G; Krauter J; Döhner K; von Neuhoff N; Schlegelberger B; Ganser A
Blood; 2006 Dec; 108(12):3898-905. PubMed ID: 16912223
[TBL] [Abstract][Full Text] [Related]
30. Menin is necessary for long term maintenance of meningioma-1 driven leukemia.
Libbrecht C; Xie HM; Kingsley MC; Haladyna JN; Riedel SS; Alikarami F; Lenard A; McGeehan GM; Ernst P; Bernt KM
Leukemia; 2021 May; 35(5):1405-1417. PubMed ID: 33542482
[TBL] [Abstract][Full Text] [Related]
31. Cell fate decisions in malignant hematopoiesis: leukemia phenotype is determined by distinct functional domains of the MN1 oncogene.
Lai CK; Moon Y; Kuchenbauer F; Starzcynowski DT; Argiropoulos B; Yung E; Beer P; Schwarzer A; Sharma A; Park G; Leung M; Lin G; Vollett S; Fung S; Eaves CJ; Karsan A; Weng AP; Humphries RK; Heuser M
PLoS One; 2014; 9(11):e112671. PubMed ID: 25401736
[TBL] [Abstract][Full Text] [Related]
32. MN1-TEL myeloid oncoprotein expressed in multipotent progenitors perturbs both myeloid and lymphoid growth and causes T-lymphoid tumors in mice.
Kawagoe H; Grosveld GC
Blood; 2005 Dec; 106(13):4278-86. PubMed ID: 16081688
[TBL] [Abstract][Full Text] [Related]
33. A Novel Inducible Mouse Model of
Stavropoulou V; Almosailleakh M; Royo H; Spetz JF; Juge S; Brault L; Kopp P; Iacovino M; Kyba M; Tzankov A; Stadler MB; Cazzaniga G; Peters AHFM; Schwaller J
Hemasphere; 2018 Aug; 2(4):e51. PubMed ID: 31723780
[TBL] [Abstract][Full Text] [Related]
34. High MN1 expression increases the in vitro clonogenic activity of primary mouse B-cells.
Numata M; Yener MD; Ekmekçi SS; Aydın M; Grosveld G; Cardone M; Terranova S; Geltink RK; Özbek U; Özçelik E; Güleç Ç; Anak S; Karaman S; Öztürk G; Akbıyık M; Kandilci A
Leuk Res; 2015 Aug; 39(8):906-12. PubMed ID: 26111797
[TBL] [Abstract][Full Text] [Related]
35. [Advance of study on MN1 gene in acute myeloid leukemia - review].
Sun HM; Qian SX; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):504-8. PubMed ID: 19379599
[TBL] [Abstract][Full Text] [Related]
36. Reversible growth factor dependency and autonomy during murine myelomonocytic leukemia induced by oncogenes.
Metcalf D; Glaser SP; Xu Z; Di Rago L; Mifsud S
Proc Natl Acad Sci U S A; 2013 Oct; 110(42):17029-34. PubMed ID: 24082086
[TBL] [Abstract][Full Text] [Related]
37. CRISPR-Cas9-induced t(11;19)/MLL-ENL translocations initiate leukemia in human hematopoietic progenitor cells
Reimer J; Knöß S; Labuhn M; Charpentier EM; Göhring G; Schlegelberger B; Klusmann JH; Heckl D
Haematologica; 2017 Sep; 102(9):1558-1566. PubMed ID: 28572162
[TBL] [Abstract][Full Text] [Related]
38. Reintroduction of CEBPA in MN1-overexpressing hematopoietic cells prevents their hyperproliferation and restores myeloid differentiation.
Kandilci A; Grosveld GC
Blood; 2009 Aug; 114(8):1596-606. PubMed ID: 19561324
[TBL] [Abstract][Full Text] [Related]
39. Preclinical modeling of cytosine arabinoside response in Mll-Enl translocator mouse leukemias.
Cano F; Pannel R; Follows GA; Rabbitts TH
Mol Cancer Ther; 2008 Mar; 7(3):730-5. PubMed ID: 18347158
[TBL] [Abstract][Full Text] [Related]
40. AMKL chimeric transcription factors are potent inducers of leukemia.
Dang J; Nance S; Ma J; Cheng J; Walsh MP; Vogel P; Easton J; Song G; Rusch M; Gedman AL; Koss C; Downing JR; Gruber TA
Leukemia; 2017 Oct; 31(10):2228-2234. PubMed ID: 28174417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
